BEIZRAY
Live / Applied — Second extension granted (statement of use) (as of 27 Jun 2025)
What this means for you
Not registered yet, but its 12 Sept 2023 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98176852
- Mark type
- Stylized text
- Filed
- 12 Sept 2023
- Published for opposition
- 07 May 2024
- Attorney of record
- Charles Ho
Goods and services
- Class 005 — Pharmaceuticals: Analgesics; Antiemetics; Biological preparations for the treatment of cancer; Blood substitute for human use; Chemical preparations for pharmaceutical or medical purposes, namely, for the treatment of cancer; Chemical reagents for medical purposes; Medicinal infusions for treating cancer; Medicinal preparations for the treatment of infectious diseases and for use in oncology; Medicines made of Chinese traditional medicinal herbs; Pharmaceutical preparations for the treatment of cancer; Pharmaceutical preparations for use in chemotherapy; Pharmaceutical products for the treatment of cancer; Prescription and non-prescription medicines, namely, pills, tablets, capsules, caplets, liquid drops, sachets and pharmaceutical preparations for the treatment of cardiovascular disorders
Owner
- Zhuhai Beihai Biotech Co., Ltd., Zhuhai, Guangdong, CN
- Zhuhai Beihai Biotech Co., Ltd., Zhuhai, Guangdong, CN
Prosecution history
- 24 Oct 2025 — TEAS STATEMENT OF USE RECEIVED
- 27 Jun 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 27 Jun 2025 — SOU EXTENSION 2 GRANTED
- 27 Jun 2025 — SOU EXTENSION 2 FILED
- 27 Jun 2025 — SOU TEAS EXTENSION RECEIVED
- 03 Mar 2025 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 31 Dec 2024 — SOU EXTENSION 1 GRANTED
- 31 Dec 2024 — SOU EXTENSION 1 FILED
- 31 Dec 2024 — SOU TEAS EXTENSION RECEIVED
- 02 Jul 2024 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 07 May 2024 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 07 May 2024 — PUBLISHED FOR OPPOSITION
- 17 Apr 2024 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 01 Apr 2024 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 21 Mar 2024 — EXAMINER'S AMENDMENT ENTERED